Leukocytoclastic vasculitis after COVID-19 vaccination
Künye
Altun, E. ve Kuzucular, E. (2022). Leukocytoclastic vasculitis after COVID-19 vaccination. Dermatologic Therapy, 35(3). https://dx.doi.org/10.1111/dth.15279Özet
Leukocytoclastic vasculitis (LCV) is the vasculitis of small vessels. In this report, we describe a 38-year-old male patient who presented to our outpatient clinic with a 1-week history of rash on his lower extremities that had started 4 days after receiving the Pfizer-BioNTech SARS-CoV-2 vaccine. A diagnosis of LCV was made based on clinical and histopathological findings. The patient was treated with antihistamines and prednisolone, after which improvement was observed in the lesions. With this paper, we aim to raise awareness concerning the possibility of LCV development after COVID-19 vaccination.
WoS Q Kategorisi
Q2Scopus Q Kategorisi
Q2Kaynak
Dermatologic TherapyCilt
35Sayı
3Koleksiyonlar
- Makale Koleksiyonu [3682]
- PubMed İndeksli Yayınlar Koleksiyonu [4091]
- Scopus İndeksli Yayınlar Koleksiyonu [6366]
- WoS İndeksli Yayınlar Koleksiyonu [6486]